![N-{22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosa…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F391627-n-22-4-dimethylamino-benzyl-6-ethyl-1023-dimethyl-581215172124-heptaoxo-13-phenyldocosahydro-12h-pyrido-21-f-pyrrolo-21-l-147101316-oxapentaazacyclononadecin-9-yl-3-hydroxypyridine-2-carboxamide.webp&w=3840&q=75)
CAS 3131-03-1: N-{22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl}-3-hydroxypyridine-2-carboxamide
Formula:C45H54N8O10
InChI:InChI=1/C45H54N8O10/c1-6-31-42(59)52-22-11-14-32(52)43(60)51(5)34(24-27-16-18-29(19-17-27)50(3)4)44(61)53-23-20-30(54)25-33(53)39(56)49-37(28-12-8-7-9-13-28)45(62)63-26(2)36(40(57)47-31)48-41(58)38-35(55)15-10-21-46-38/h7-10,12-13,15-19,21,26,31-34,36-37,55H,6,11,14,20,22-25H2,1-5H3,(H,47,57)(H,48,58)(H,49,56)/t26?,31?,32?,33?,34-,36?,37?/m0/s1
SMILES:CCC1C(=O)N2CCCC2C(=O)N(C)[C@@H](Cc2ccc(cc2)N(C)C)C(=O)N2CCC(=O)CC2C(=NC(c2ccccc2)C(=O)OC(C)C(C(=N1)O)N=C(c1c(cccn1)O)O)O
Synonyms:- 2-pyridinecarboxamide, N-[22-[[4-(dimethylamino)phenyl]methyl]-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxy-
Sort by
Found 4 products.
Pristinamycin IA
CAS:Pristinamycin IA is a streptogramin antibiotic, which is a natural product derived from the bacterium *Streptomyces pristinaespiralis*. It operates by inhibiting bacterial protein synthesis through the disruption of ribosomal function, specifically targeting the 50S ribosomal subunit. This mode of action is effective in halting bacterial growth, making it particularly significant in combating resistant strains. Pristinamycin IA is used primarily to treat infections caused by Gram-positive bacteria, including those strains resistant to other antibiotics like penicillin and methicillin. Its applications are crucial in clinical settings where antibiotic resistance poses a significant threat to treatment efficacy. The compound’s ability to synergistically enhance the action of other antibiotics also broadens its utility in multidrug regimens. Research into its pharmacokinetics and effectiveness continues to expand, ensuring its role in advancing antibacterial therapy.Formula:C45H54N8O10Purity:Min. 95%Molecular weight:866.96 g/molPristinamycin IA
CAS:Pristinamycin IA (Mikamycin B) is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.Formula:C45H54N8O10Purity:97.92%Color and Shape:SolidMolecular weight:866.96
